Prota raises US$21M led by Singapore’s SPRIM for its peanut allergy therapy

Singapore-based health sciences VC firm SPRIM Global Investments has led the US$21 million funding round (equity and debt) of Australian biotech firm Prota Therapeutics. The fresh funding will be used to advance the development of Prota’s peanut allergy rAds Links by Easy Branches
Play online games for free at games.easybranches.com

Guest Post Services www.easybranches.com/contribute